Krystal Biotech price target raised to $215 from $206 at Citi
Citi analyst Yigal Nochomovitz raised the firm’s price target on Krystal Biotech (KRYS) to $215 from $206 and keeps a Neutral rating on the ...
Krystal Biotech sees non-GAAP R&D and SG&A expense $150.0M-$175.0M
EST Krystal Biotech (KRYS) sees non-GAAP R&D and SG&A expense $150.0M-$175.0M Discover the Best Stocks and Maximize Your ...
2025 NFL free agency primer: Projected free agents, top needs, cap space for all 32 teams this offseason
NFL offseason is officially here. Teams can start placing the franchise tag on unrestricted free agents beginning Tuesday, ...
Wall Street Journal1d
Krystal Biotech Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
NPR2d
Think
Keon West, social psychologist at Goldsmiths at the University of London, joins host Krys Boyd to discuss his rigorous research into racist beliefs, the results of social experiments that show how ...
MarketWatch1d
Krystal Biotech Inc.
4D Molecular Therapeutics Inc. 3.39% $225.59M ...
inkbotdesign.com6d
Patagonia Logo Design: The Art of Brand Identity
Most outdoor brand logos are bland as a soggy sandwich left out in the rain. But not Patagonia's. Their logo is like a breath of fresh mountain air in a world of corporate stuffiness. I remember the ...